Highest development stage: Preclinical

Development status: Inactive

Gram-negative activity

Mechanism of Action/Target pathogen: Anti-pseudomonal activity

Additional information: Ganguli BN, Nadarni SR, Patel MV, et al. Napsamycins new anti-pseudomonas antibiotics. 32nd-Intersci-Conf-Antimicrobial-Agents-Chemother 1992; 195